{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-000370","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2026-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.095872+00:00","generated_at":"2026-05-16T09:55:42.798810+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"confidence":"high","headline":"Coeptis Therapeutics receives Nasdaq delisting notice for missing annual meeting; meeting set for Jan 30","bullets":["Nasdaq letter on Jan 12, 2026 cites violation of Listing Rules 5620(a) and 5810(c)(2)(G) for failing to hold annual meeting within 12 months of fiscal year end (Dec 31, 2024).","Company has 45 days to submit compliance plan; if accepted, Nasdaq may grant exception until June 29, 2026.","Annual meeting scheduled for January 30, 2026, which Coeptis believes will cure the deficiency.","Ticker: COEP (Nasdaq); warrants trade as COEPW."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-000370","json":"https://secwatch.observer/filing/0001683168-26-000370.json","markdown":"https://secwatch.observer/filing/0001683168-26-000370.md","text":"https://secwatch.observer/filing/0001683168-26-000370.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316826000370/0001683168-26-000370-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316826000370/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:55:42.798810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}